In addition the ALOX5AP gene variations are associated with CAD risk in patients with familial hypercholesterolemia [15], stroke in Iranian, Chinese [16,17], and premature CAD in European American patients [18]. This evidence concerns the gene ALOX5AP and coronary artery disorder.